PRIVATE TRUST CO NA - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRIVATE TRUST CO NA ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$42,589
-24.6%
1,5850.0%0.01%
-14.3%
Q2 2023$56,521
+40.4%
1,5850.0%0.01%
+40.0%
Q1 2023$40,259
+62804.7%
1,5850.0%0.01%
-44.4%
Q4 2022$64
-99.9%
1,5850.0%0.01%
+12.5%
Q3 2022$52,000
-7.1%
1,5850.0%0.01%
-11.1%
Q2 2022$56,0001,5850.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders